< Back to previous page

Project

Monitoring HPV vaccine impact in low- and middle- income countries with repeat urine surveys.

Monitoring the impact of HPV vaccination through surveys of HPV DNA prevalence in urine samples from adolescents. Many low/middle-income countries are implementing national human papillomavirus (HPV) vaccination. Establishing baseline pre-vaccination prevalence is crucial to quantify later the impact of a vaccination program. HPV prevalence can be estimated in school-attending women aged 18 to 20 years by urine-based surveys according to a standardized protocol for study population recruitment, urine collection, DNA extraction, and HPV testing and genotyping. In addition to HPV also Chlamydia can be tested on the same samples.
Date:1 Oct 2018 →  Today
Keywords:VACCINATION
Disciplines:Public health care, Public health sciences, Public health services